A detailed history of Dakota Wealth Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Dakota Wealth Management holds 23,984 shares of NVO stock, worth $2.15 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
23,984
Previous 33,908 29.27%
Holding current value
$2.15 Million
Previous $4.04 Million 48.9%
% of portfolio
0.05%
Previous 0.09%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

SELL
$85.0 - $120.04 $843,540 - $1.19 Million
-9,924 Reduced 29.27%
23,984 $2.06 Million
Q3 2024

Oct 23, 2024

SELL
$119.07 - $145.42 $351,851 - $429,716
-2,955 Reduced 8.02%
33,908 $4.04 Million
Q2 2024

Jul 19, 2024

SELL
$122.71 - $146.91 $111,666 - $133,688
-910 Reduced 2.41%
36,863 $5.26 Million
Q1 2024

Apr 24, 2024

BUY
$102.11 - $135.92 $1.45 Million - $1.93 Million
14,221 Added 60.38%
37,773 $4.85 Million
Q4 2023

Jan 30, 2024

SELL
$87.78 - $105.45 $108,057 - $129,808
-1,231 Reduced 4.97%
23,552 $2.44 Million
Q3 2023

Oct 23, 2023

BUY
$90.94 - $199.54 $1.17 Million - $2.58 Million
12,909 Added 108.72%
24,783 $2.25 Million
Q2 2023

Jul 31, 2023

BUY
$155.98 - $172.65 $809,536 - $896,053
5,190 Added 77.65%
11,874 $1.92 Million
Q1 2023

Apr 14, 2023

BUY
$132.34 - $159.14 $16,807 - $20,210
127 Added 1.94%
6,684 $1.06 Million
Q4 2022

Feb 07, 2023

BUY
$102.55 - $135.33 $4,512 - $5,954
44 Added 0.68%
6,557 $887,000
Q3 2022

Nov 10, 2022

BUY
$95.28 - $116.93 $2,763 - $3,390
29 Added 0.45%
6,513 $649,000
Q2 2022

Aug 05, 2022

BUY
$103.24 - $121.81 $669,408 - $789,816
6,484 New
6,484 $722,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $202B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Dakota Wealth Management Portfolio

Follow Dakota Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dakota Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Dakota Wealth Management with notifications on news.